List of Excipients in API bisoprolol fumarate and hydrochlorothiazide
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing bisoprolol fumarate and hydrochlorothiazide
| Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
|---|---|---|---|---|---|
| Teva Pharmaceuticals USA Inc | BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE | bisoprolol fumarate and hydrochlorothiazide | 0093-3241 | ANHYDROUS DIBASIC CALCIUM PHOSPHATE | |
| Teva Pharmaceuticals USA Inc | BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE | bisoprolol fumarate and hydrochlorothiazide | 0093-3241 | CELLULOSE, MICROCRYSTALLINE | |
| Teva Pharmaceuticals USA Inc | BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE | bisoprolol fumarate and hydrochlorothiazide | 0093-3241 | CROSPOVIDONE | |
| Teva Pharmaceuticals USA Inc | BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE | bisoprolol fumarate and hydrochlorothiazide | 0093-3241 | FERRIC OXIDE YELLOW | |
| >Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Excipients in ANDA-approved (generic) drugs containing bisoprolol fumarate and hydrochlorothiazide
Detailed excipient profiles for bisoprolol fumarate and hydrochlorothiazide
Excipient focus: ANHYDROUS DIBASIC CALCIUM PHOSPHATE
bisoprolol fumarate and hydrochlorothiazide drug variants containing ANHYDROUS DIBASIC CALCIUM PHOSPHATE
bisoprolol fumarate and hydrochlorothiazide drug variants not containing ANHYDROUS DIBASIC CALCIUM PHOSPHATE
Excipient focus: ANHYDROUS LACTOSE
bisoprolol fumarate and hydrochlorothiazide drug variants containing ANHYDROUS LACTOSE
bisoprolol fumarate and hydrochlorothiazide drug variants not containing ANHYDROUS LACTOSE
Excipient focus: BUTYLATED HYDROXYANISOLE
bisoprolol fumarate and hydrochlorothiazide drug variants containing BUTYLATED HYDROXYANISOLE
| Company | Ingredient | NDC |
|---|---|---|
| Zydus Lifesciences Limited | bisoprolol fumarate and hydrochlorothiazide | 70771-1760 |
| Viona Pharmaceuticals Inc | bisoprolol fumarate and hydrochlorothiazide | 72578-113 |
| >Company | >Ingredient | >NDC |
bisoprolol fumarate and hydrochlorothiazide drug variants not containing BUTYLATED HYDROXYANISOLE
Excipient focus: CALCIUM PHOSPHATE, DIBASIC, ANHYDROUS
bisoprolol fumarate and hydrochlorothiazide drug variants containing CALCIUM PHOSPHATE, DIBASIC, ANHYDROUS
bisoprolol fumarate and hydrochlorothiazide drug variants not containing CALCIUM PHOSPHATE, DIBASIC, ANHYDROUS
Excipient focus: CELLULOSE, MICROCRYSTALLINE
bisoprolol fumarate and hydrochlorothiazide drug variants containing CELLULOSE, MICROCRYSTALLINE
bisoprolol fumarate and hydrochlorothiazide drug variants not containing CELLULOSE, MICROCRYSTALLINE
| Company | Ingredient | NDC |
|---|---|---|
| Zydus Lifesciences Limited | bisoprolol fumarate and hydrochlorothiazide | 70771-1760 |
| Viona Pharmaceuticals Inc | bisoprolol fumarate and hydrochlorothiazide | 72578-113 |
| >Company | >Ingredient | >NDC |
Excipient focus: COPOVIDONE
bisoprolol fumarate and hydrochlorothiazide drug variants containing COPOVIDONE
bisoprolol fumarate and hydrochlorothiazide drug variants not containing COPOVIDONE
Excipient focus: COPOVIDONE K25-31
bisoprolol fumarate and hydrochlorothiazide drug variants containing COPOVIDONE K25-31
bisoprolol fumarate and hydrochlorothiazide drug variants not containing COPOVIDONE K25-31
Excipient focus: CROSCARMELLOSE SODIUM
bisoprolol fumarate and hydrochlorothiazide drug variants containing CROSCARMELLOSE SODIUM
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | bisoprolol fumarate and hydrochlorothiazide | 0378-0501 |
| REMEDYREPACK INC | bisoprolol fumarate and hydrochlorothiazide | 70518-3207 |
| REMEDYREPACK INC | bisoprolol fumarate and hydrochlorothiazide | 70518-3333 |
| >Company | >Ingredient | >NDC |
bisoprolol fumarate and hydrochlorothiazide drug variants not containing CROSCARMELLOSE SODIUM
Excipient focus: CROSPOVIDONE
bisoprolol fumarate and hydrochlorothiazide drug variants containing CROSPOVIDONE
bisoprolol fumarate and hydrochlorothiazide drug variants not containing CROSPOVIDONE
Excipient focus: D&C RED NO. 30
bisoprolol fumarate and hydrochlorothiazide drug variants containing D&C RED NO. 30
| Company | Ingredient | NDC |
|---|---|---|
| A-S Medication Solutions | bisoprolol fumarate and hydrochlorothiazide | 50090-5849 |
| Bryant Ranch Prepack | bisoprolol fumarate and hydrochlorothiazide | 71335-1769 |
| >Company | >Ingredient | >NDC |
bisoprolol fumarate and hydrochlorothiazide drug variants not containing D&C RED NO. 30
Excipient focus: D&C YELLOW NO. 10
bisoprolol fumarate and hydrochlorothiazide drug variants containing D&C YELLOW NO. 10
| Company | Ingredient | NDC |
|---|---|---|
| Edenbridge Pharmaceuticals LLC | bisoprolol fumarate and hydrochlorothiazide | 42799-920 |
| Bryant Ranch Prepack | bisoprolol fumarate and hydrochlorothiazide | 71335-1931 |
| >Company | >Ingredient | >NDC |
bisoprolol fumarate and hydrochlorothiazide drug variants not containing D&C YELLOW NO. 10
Excipient focus: DIBASIC CALCIUM PHOSPHATE DIHYDRATE
bisoprolol fumarate and hydrochlorothiazide drug variants containing DIBASIC CALCIUM PHOSPHATE DIHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| A-S Medication Solutions | bisoprolol fumarate and hydrochlorothiazide | 50090-6030 |
| GLENMARK PHARMACEUTICALS INC USA | bisoprolol fumarate and hydrochlorothiazide | 68462-878 |
| >Company | >Ingredient | >NDC |
bisoprolol fumarate and hydrochlorothiazide drug variants not containing DIBASIC CALCIUM PHOSPHATE DIHYDRATE
Excipient focus: FD&C RED NO. 40
bisoprolol fumarate and hydrochlorothiazide drug variants containing FD&C RED NO. 40
| Company | Ingredient | NDC |
|---|---|---|
| Rebel Distributors Corp | bisoprolol fumarate and hydrochlorothiazide | 21695-808 |
| Bryant Ranch Prepack | bisoprolol fumarate and hydrochlorothiazide | 63629-4072 |
| >Company | >Ingredient | >NDC |
bisoprolol fumarate and hydrochlorothiazide drug variants not containing FD&C RED NO. 40
Excipient focus: FD&C YELLOW NO. 6
bisoprolol fumarate and hydrochlorothiazide drug variants containing FD&C YELLOW NO. 6
bisoprolol fumarate and hydrochlorothiazide drug variants not containing FD&C YELLOW NO. 6
Excipient focus: FERRIC OXIDE RED
bisoprolol fumarate and hydrochlorothiazide drug variants containing FERRIC OXIDE RED
bisoprolol fumarate and hydrochlorothiazide drug variants not containing FERRIC OXIDE RED
Excipient focus: FERRIC OXIDE YELLOW
bisoprolol fumarate and hydrochlorothiazide drug variants containing FERRIC OXIDE YELLOW
bisoprolol fumarate and hydrochlorothiazide drug variants not containing FERRIC OXIDE YELLOW
Excipient focus: FERROSOFERRIC OXIDE
bisoprolol fumarate and hydrochlorothiazide drug variants containing FERROSOFERRIC OXIDE
| Company | Ingredient | NDC |
|---|---|---|
| A-S Medication Solutions | bisoprolol fumarate and hydrochlorothiazide | 50090-6413 |
| >Company | >Ingredient | >NDC |
bisoprolol fumarate and hydrochlorothiazide drug variants not containing FERROSOFERRIC OXIDE
Excipient focus: HYPROMELLOSE
bisoprolol fumarate and hydrochlorothiazide drug variants containing HYPROMELLOSE
bisoprolol fumarate and hydrochlorothiazide drug variants not containing HYPROMELLOSE
Excipient focus: HYPROMELLOSE 2910
bisoprolol fumarate and hydrochlorothiazide drug variants containing HYPROMELLOSE 2910
bisoprolol fumarate and hydrochlorothiazide drug variants not containing HYPROMELLOSE 2910
Excipient focus: HYPROMELLOSES
bisoprolol fumarate and hydrochlorothiazide drug variants containing HYPROMELLOSES
bisoprolol fumarate and hydrochlorothiazide drug variants not containing HYPROMELLOSES
Excipient focus: MAGNESIUM STEARATE
bisoprolol fumarate and hydrochlorothiazide drug variants containing MAGNESIUM STEARATE
bisoprolol fumarate and hydrochlorothiazide drug variants not containing MAGNESIUM STEARATE
Excipient focus: MICROCRYSTALLINE CELLULOSE 102
bisoprolol fumarate and hydrochlorothiazide drug variants containing MICROCRYSTALLINE CELLULOSE 102
| Company | Ingredient | NDC |
|---|---|---|
| Zydus Lifesciences Limited | bisoprolol fumarate and hydrochlorothiazide | 70771-1760 |
| Viona Pharmaceuticals Inc | bisoprolol fumarate and hydrochlorothiazide | 72578-113 |
| >Company | >Ingredient | >NDC |
bisoprolol fumarate and hydrochlorothiazide drug variants not containing MICROCRYSTALLINE CELLULOSE 102
Excipient focus: POLYDEXTROSE
bisoprolol fumarate and hydrochlorothiazide drug variants containing POLYDEXTROSE
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | bisoprolol fumarate and hydrochlorothiazide | 0378-0501 |
| REMEDYREPACK INC | bisoprolol fumarate and hydrochlorothiazide | 70518-3207 |
| REMEDYREPACK INC | bisoprolol fumarate and hydrochlorothiazide | 70518-3333 |
| >Company | >Ingredient | >NDC |
bisoprolol fumarate and hydrochlorothiazide drug variants not containing POLYDEXTROSE
Excipient focus: POLYETHYLENE GLYCOL
bisoprolol fumarate and hydrochlorothiazide drug variants containing POLYETHYLENE GLYCOL
bisoprolol fumarate and hydrochlorothiazide drug variants not containing POLYETHYLENE GLYCOL
Excipient focus: POLYETHYLENE GLYCOL 400
bisoprolol fumarate and hydrochlorothiazide drug variants containing POLYETHYLENE GLYCOL 400
bisoprolol fumarate and hydrochlorothiazide drug variants not containing POLYETHYLENE GLYCOL 400
Excipient focus: POLYETHYLENE GLYCOL 4000
bisoprolol fumarate and hydrochlorothiazide drug variants containing POLYETHYLENE GLYCOL 4000
| Company | Ingredient | NDC |
|---|---|---|
| A-S Medication Solutions | bisoprolol fumarate and hydrochlorothiazide | 50090-6030 |
| GLENMARK PHARMACEUTICALS INC USA | bisoprolol fumarate and hydrochlorothiazide | 68462-878 |
| >Company | >Ingredient | >NDC |
bisoprolol fumarate and hydrochlorothiazide drug variants not containing POLYETHYLENE GLYCOL 4000
Excipient focus: POLYETHYLENE GLYCOL 6000
bisoprolol fumarate and hydrochlorothiazide drug variants containing POLYETHYLENE GLYCOL 6000
bisoprolol fumarate and hydrochlorothiazide drug variants not containing POLYETHYLENE GLYCOL 6000
Excipient focus: POLYETHYLENE GLYCOL 8000
bisoprolol fumarate and hydrochlorothiazide drug variants containing POLYETHYLENE GLYCOL 8000
| Company | Ingredient | NDC |
|---|---|---|
| Zydus Lifesciences Limited | bisoprolol fumarate and hydrochlorothiazide | 70771-1760 |
| Viona Pharmaceuticals Inc | bisoprolol fumarate and hydrochlorothiazide | 72578-113 |
| >Company | >Ingredient | >NDC |
bisoprolol fumarate and hydrochlorothiazide drug variants not containing POLYETHYLENE GLYCOL 8000
Excipient focus: POLYETHYLENE GLYCOLS
bisoprolol fumarate and hydrochlorothiazide drug variants containing POLYETHYLENE GLYCOLS
| Company | Ingredient | NDC |
|---|---|---|
| Bryant Ranch Prepack | bisoprolol fumarate and hydrochlorothiazide | 63629-4072 |
| >Company | >Ingredient | >NDC |
bisoprolol fumarate and hydrochlorothiazide drug variants not containing POLYETHYLENE GLYCOLS
Excipient focus: POLYSORBATE 80
bisoprolol fumarate and hydrochlorothiazide drug variants containing POLYSORBATE 80
bisoprolol fumarate and hydrochlorothiazide drug variants not containing POLYSORBATE 80
Excipient focus: SILICON DIOXIDE
bisoprolol fumarate and hydrochlorothiazide drug variants containing SILICON DIOXIDE
bisoprolol fumarate and hydrochlorothiazide drug variants not containing SILICON DIOXIDE
Excipient focus: SODIUM LAURYL SULFATE
bisoprolol fumarate and hydrochlorothiazide drug variants containing SODIUM LAURYL SULFATE
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | bisoprolol fumarate and hydrochlorothiazide | 0378-0501 |
| REMEDYREPACK INC | bisoprolol fumarate and hydrochlorothiazide | 70518-3207 |
| REMEDYREPACK INC | bisoprolol fumarate and hydrochlorothiazide | 70518-3333 |
| >Company | >Ingredient | >NDC |
bisoprolol fumarate and hydrochlorothiazide drug variants not containing SODIUM LAURYL SULFATE
Excipient focus: STARCH, CORN
bisoprolol fumarate and hydrochlorothiazide drug variants containing STARCH, CORN
bisoprolol fumarate and hydrochlorothiazide drug variants not containing STARCH, CORN
| Company | Ingredient | NDC |
|---|---|---|
| Zydus Lifesciences Limited | bisoprolol fumarate and hydrochlorothiazide | 70771-1760 |
| Viona Pharmaceuticals Inc | bisoprolol fumarate and hydrochlorothiazide | 72578-113 |
| >Company | >Ingredient | >NDC |
Excipient focus: STEARIC ACID
bisoprolol fumarate and hydrochlorothiazide drug variants containing STEARIC ACID
bisoprolol fumarate and hydrochlorothiazide drug variants not containing STEARIC ACID
Excipient focus: TITANIUM DIOXIDE
bisoprolol fumarate and hydrochlorothiazide drug variants containing TITANIUM DIOXIDE
bisoprolol fumarate and hydrochlorothiazide drug variants not containing TITANIUM DIOXIDE
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
© Copyright 2002-2024 thinkBiotech LLC
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - HIPAA-ready chat for life sciences
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - HIPAA-ready chat for life sciences
Preferred Citation:
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Links
Follow DrugPatentWatch:
